Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Current Opinion in Oncology
|
October 1, 2025
Open questions on vorasidenib
Antoine Seyve, François Ducray
European Journal of Neurology
|
July 15, 2026
Diagnostic Value of Spinal Cord Lesion Metabolism on [<sup>18</sup>F]FDG PET/CT for the Classification of Myelopathy
Antoine Gavoille, Anthime Flaus, Matthieu Dietz, et al.
La Radiologia Medica
|
October 3, 2025
CMRO<sub>2</sub> (DSC-PW) perfusion parameter helps to distinguish between progression and pseudoprogression in patients with glioblastoma
Emanuele Tommasino, François Ducray, Antoine Seyve, et al.
Cancers
|
October 26, 2024
Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases
Grigorios Gkasdaris, Julien Berthiller, Jacques Guyotat, et al.
Neuro-Oncology
|
October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort
Domique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Journal of Neuro-Oncology
|
June 27, 2024
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location
Souhir Guidara, Antoine Seyve, Delphine Poncet, et al.
European Journal of Neurology
|
May 19, 2023
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone
Inés Esparragosa Vazquez, Mané Ndiaye, Anna Luisa Di Stefano, et al.
Clinical Neurology and Neurosurgery
|
June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma
Antoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.
Frontiers in Neurology
|
February 9, 2024
Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma
Antonio Farina, Manon Escalere, Matthias Dion, et al.
Nature Communications
|
January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells
Sébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Current Opinion in Oncology
|
October 1, 2025
Open questions on vorasidenib
Antoine Seyve, François Ducray
European Journal of Neurology
|
July 15, 2026
Diagnostic Value of Spinal Cord Lesion Metabolism on [<sup>18</sup>F]FDG PET/CT for the Classification of Myelopathy
Antoine Gavoille, Anthime Flaus, Matthieu Dietz, et al.
La Radiologia Medica
|
October 3, 2025
CMRO<sub>2</sub> (DSC-PW) perfusion parameter helps to distinguish between progression and pseudoprogression in patients with glioblastoma
Emanuele Tommasino, François Ducray, Antoine Seyve, et al.
Cancers
|
October 26, 2024
Is Carmustine Wafer Implantation in Progressive High-Grade Gliomas a Relevant Therapeutic Option? Complication Rate, Predictors of Complications and Onco-Functional Outcomes in a Series of 53 Cases
Grigorios Gkasdaris, Julien Berthiller, Jacques Guyotat, et al.
Neuro-Oncology
|
October 21, 2024
Reappraisal of prognostic factors in CNS WHO grade 3 oligodendrogliomas IDH-mutant and 1p/19q co-deleted: Lessons from the French POLA cohort
Domique Figarella-Branger, Carole Colin, Karima Mokhtari, et al.
Journal of Neuro-Oncology
|
June 27, 2024
Characteristics of H3K27M-mutant diffuse gliomas with a non-midline location
Souhir Guidara, Antoine Seyve, Delphine Poncet, et al.
European Journal of Neurology
|
May 19, 2023
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone
Inés Esparragosa Vazquez, Mané Ndiaye, Anna Luisa Di Stefano, et al.
Clinical Neurology and Neurosurgery
|
June 20, 2020
Initial surgical resection and long time to occurrence from initial diagnosis are independent prognostic factors in resected recurrent IDH wild-type glioblastoma
Antoine Seyve, Fernando Lozano-Sanchez, Alice Thomas, et al.
Frontiers in Neurology
|
February 9, 2024
Mononeuritis multiplex following immune checkpoint inhibitors in malignant pleural mesothelioma
Antonio Farina, Manon Escalere, Matthias Dion, et al.
Nature Communications
|
January 23, 2023
RSL24D1 sustains steady-state ribosome biogenesis and pluripotency translational programs in embryonic stem cells
Sébastien Durand, Marion Bruelle, Fleur Bourdelais, et al.
Page
of 2